Works matching IS 11753277 AND DT 2003 AND VI 3 AND IP 3
1
- American Journal of Cardiovascular Drugs, 2003, v. 3, n. 3, p. 169, doi. 10.2165/00129784-200303030-00003
- Article
2
- American Journal of Cardiovascular Drugs, 2003, v. 3, n. 3, p. 211, doi. 10.2165/00129784-200303030-00007
- Kate McKeage;
- David Murdoch;
- Karen L. Goa
- Article
3
- American Journal of Cardiovascular Drugs, 2003, v. 3, n. 3, p. 193, doi. 10.2165/00129784-200303030-00005
- Janice P. Lea;
- Denyse T. Brown;
- Michael Lipkowitz;
- John Middleton;
- Keith Norris
- Article
4
- American Journal of Cardiovascular Drugs, 2003, v. 3, n. 3, p. 179, doi. 10.2165/00129784-200303030-00004
- Article
5
- American Journal of Cardiovascular Drugs, 2003, v. 3, n. 3, p. 163, doi. 10.2165/00129784-200303030-00002
- Peter Jepsen;
- Søren P Johnsen;
- Henrik T Sørensen
- Article
6
- American Journal of Cardiovascular Drugs, 2003, v. 3, n. 3, p. 201, doi. 10.2165/00129784-200303030-00006
- Jeffrey I. Weitz;
- Mark A. Crowther
- Article
7
- American Journal of Cardiovascular Drugs, 2003, v. 3, n. 3, p. 149, doi. 10.2165/00129784-200303030-00001
- Raymond G. Schlienger;
- Christoph R. Meier
- Article
